Use of tamoxifen with postsurgical irradiation may improve survival in estrogen and progesterone receptor-positive male breast cancer

Clinical Breast Cancer

Volumn 11, Issue 1, 2011, Pages 39-45

  Fogh, Shannon ^a,d   Hirsch, Ariel E ^a   Langmead, Jon P ^e   Goldberg, Saveli I ^b   Rosenberg, Carol L ^a   Taghian, Alphonse G ^b   Powell, Simon N ^c   Kachnic, Lisa A ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e NONE

Author keywords

Adjuvant therapy; Radiation therapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; PACLITAXEL; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MALE; RETROSPECTIVE STUDY;

EID: 79953789925     PISSN: 15268209     EISSN: 19380666     Source Type: Journal    
DOI: 10.3816/CBC.2011.n.007     Document Type: Article

References (38)

1. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004; 54:8-29. (Pubitemid 38443417)
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58:71-96. (Pubitemid 351521864)
3. Anderson WF, Althuis MD, Brinton LA, et al. Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat 2004; 83:77-86. (Pubitemid 38141895)
4. Sasco AJ, Lowenfels AB, Pasker-de Jong P. Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer 1993; 53:538-49. (Pubitemid 23069261)
5. Cutuli B, Lacroze M, Dilhuydy JM, et al. Male breast cancer: results of the treatments and prognostic factors in 397 cases. Eur J Cancer 1995; 31A:1960-4. (Pubitemid 26023085)
6. Yildirim E, Berberoglu U. Male breast cancer: a 22-year experience. Eur J Surg Oncol 1998; 24:548-52. (Pubitemid 28566902)
7. Fisher B, Bryant J, Dignam JJ, et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 2002; 20:4141-9. (Pubitemid 35191016)
8. Fyles AW, McCready DR, Manchul LA, et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 2004; 351:963-70.
9. Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 2004; 351:971-7. (Pubitemid 39166260)
10. Digenis AG, Ross CB, Morrison JG, et al. Carcinoma of the male breast: a review of 41 cases. South Med J 1990; 83:1162-7. (Pubitemid 20361756)
11. Goss PE, Reid C, Pintilie M, et al. Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996. Cancer 1999; 85:629-39. (Pubitemid 29075284)
12. Ribeiro G, Swindell R. Adjuvant tamoxifen for male breast cancer (MBC). Br J Cancer 1992; 65:252-4.
13. Cutuli B. Strategies in treating male breast cancer. Expert Opin Pharmacother 2007; 8:193-202. (Pubitemid 46206621)
14. Ben Dhiab T, Bouzid T, Gamoudi A, et al. Male breast cancer: about 123 cases collected at the Institute Salah-Azaiz of Tunis from 1979 to 1999. Bull Cancer 2005; 92:281-5. (Pubitemid 40562433)
15. Agrawal A, Ayantunde AA, Rampaul R, et al. Male breast cancer: a review of clinical management. Breast Cancer Res Treat 2007; 103:11-21. (Pubitemid 46653271)
16. Chakravarthy A, Kim CR. Post-mastectomy radiation in male breast cancer. Radiother Oncol 2002; 65:99-103. (Pubitemid 35346555)
17. Donegan WL, Redlich PN, Lang PJ, et al. Carcinoma of the breast in males: a multiinstitutional survey. Cancer 1998; 83:498-509. (Pubitemid 28354506)
18. Joshi MG, Lee AK, Loda M, et al. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer 1996; 77:490-8. (Pubitemid 26047570)
19. Salvadori B, Saccozzi R, Manzari A, et al. Prognosis of breast cancer in males: an analysis of 170 cases. Eur J Cancer 1994; 30A:930-5. (Pubitemid 24256237)
20. Vetto J, Jun SY, Paduch D, et al. Stages at presentation, prognostic factors, and outcome of breast cancer in males. Am J Surg 1999; 177:379-83. (Pubitemid 29252805)
21. Guinee VF, Olsson H, Moller T, et al. The prognosis of breast cancer in males. A report of 335 cases. Cancer 1993; 71:154-61. (Pubitemid 23019296)
22. Herman K, Lobaziewicz W, Skotnicki P, et al. Male breast cancer. Does the prognosis differ compared to female? Neoplasma 2000; 47:191-5. (Pubitemid 30643254)
23. Anderson WF, Chu K, Chatterjee N, et al. Male breast cancer in the SEER database. Proc Am Soc Clin Oncol 2001; 20.
24. Thomas DB. Breast cancer in men. Epidemiol Rev 1993; 15:220-31. (Pubitemid 23269085)
25. O'Malley CD, Prehn AW, Shema SJ, et al. Racial/ethnic differences in survival rates in a population-based series of men with breast carcinoma. Cancer 2002; 94:2836-43. (Pubitemid 34547681)
26. Giordano SH, Buzdar AU, Hortobagyi GN. Breast cancer in men. Ann Intern Med 2002; 137:678-87. (Pubitemid 35176102)
27. Rayson D, Erlichman C, Suman VJ, et al. Molecular markers in male breast carcinoma. Cancer 1998; 83:1947-55. (Pubitemid 28503726)
28. Willsher PC, Leach IH, Ellis IO, et al. Male breast cancer: pathological and immunohistochemical features. Anticancer Res 1997; 17:2335-8. (Pubitemid 27320993)
29. Ciatto S, Iossa A, Bonardi R, et al. Male breast carcinoma: review of a multicenter series of 150 cases. Coordinating Center and Writing Committee of FONCAM (National Task Force for Breast Cancer), Italy. Tumori 1990; 76:555-8.
30. Michaels BM, Nunn CR, Roses DF. Lobular carcinoma of the male breast. Surgery 1994; 115:402-5. (Pubitemid 24098335)
31. Giordano SH, Perkins GH, Broglio K, et al. Adjuvant systemic therapy for male breast carcinoma. Cancer 2005; 104:2359-64. (Pubitemid 41691556)
32. Anelli TF, Anelli A, Tran KN, et al. Tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patients. Cancer 1994; 74:74-7. (Pubitemid 24187612)
33. Lopez M, Di Lauro L, Lazzaro B, et al. Hormonal treatment of disseminated male breast cancer. Oncology 1985; 42:345-9. (Pubitemid 16213236)
34. Harris AL, Dowsett M, Stuart-Harris R, et al. Role of aminoglutethimide in male breast cancer. Br J Cancer 1986; 54:657-60. (Pubitemid 17182696)
35. Osborne CK. Tamoxifen in the treatment of breast cancer. N Engl J Med 1998; 339:1609-18. (Pubitemid 28536137)
36. Spence RA, MacKenzie G, Anderson JR, et al. Long-term survival following cancer of the male breast in Northern Ireland. A report of 81 cases. Cancer 1985; 55:648-52. (Pubitemid 15156038)
37. Erlichman C, Murphy KC, Elhakim T. Male breast cancer: a 13-year review of 89 patients. J Clin Oncol 1984; 2:903-9. (Pubitemid 14037768)
38. Schuchardt U, Seegenschmiedt MH, Kirschner MJ, et al. Adjuvant radiotherapy for breast carcinoma in men: a 20-year clinical experience. Am J Clin Oncol 1996; 19:330-6. (Pubitemid 26242226)